Navigation Links
Research shows single-patient rooms reduce hospital infections in ICU
Date:1/11/2011

This release is available in French.

Montreal, January 10, 2011 A research team from the McGill University Health Centre (MUHC) and McGill University has demonstrated that private rooms in the Intensive Care Unit (ICU) play a key role in reducing hospital infections like C-difficile. The study, published today in the journal Archives of Internal Medicine, also suggests that length of stay would be shorter and this could lead to cost savings to the healthcare system.

Infection control in hospitals is a worldwide health concern that can have a serious impact on patient morbidity, mortality and the cost of treatment particularly in the ICU, where patients are highly susceptible to infection. Single-patient rooms have long been considered to provide patients with better protection from hospital infections. However, previous studies investigating this issue have been inconclusive. "We had a valuable opportunity to examine the rates of acquisition of infection in patients during a change from multi-bed to single rooms in the ICU at the MUHC," explains Dana Teltsch, lead author of the study and Ph.D. candidate in the Dept. of Epidemiology, Biostatistics and Occupational Health at McGill.

The results show that the infection acquisition rate after room privatization fell about 50 percent for three bacteria of most concern Staphylococcus aureus (MRSA), C-difficile and Enterococcus (VRE). "We also observed a 10 percent reduction in the length of stay in the ICU after changing to private rooms. These findings provide a basis of comparison of the savings versus the costs to the healthcare system on top of the health benefits to patients," said Teltsch. It is estimated each case of C. difficile can cost of up to $7000 per episode.

"This study is the first evaluation of the full range of the benefits of private rooms in an ICU environment and highlights the important role that physical infrastructure plays in the prevention of transmission of healthcare associated pathogens," said Dr. Vivian Loo, one the co-author's of the study, Chief of Microbiology at the MUHC and Associate Professor in McGill's Department of Medicine. "Of course, other factors are also important in preventing transmission, like hand hygiene, isolation precautions, antibiotic stewardship and housekeeping practices, but this study clearly demonstrates the crucial need for private rooms, particularly for this patient population."

"Private rooms can help our patients avoid infections and also aid the healthcare system as a whole in decreasing length of stay associated with hospital-acquired infections," says Dr. David Buckeridge, senior author, Associate Professor in the Dept. of Epidemiology, Biostatistics and Occupational Health at McGill and a Medical Scientist in the Department of Medicine at the Research Institute of the MUHC. "We did not measure all of the costs and benefits of private rooms in our study, but they are an investment that, once built, should continue to provide substantial benefit."

All rooms at the New MUHC, at the Glen, Lachine and Mountain campuses, will be single-patient rooms where natural light, a comfortable family area, and a private bathroom will contribute to the healing of both body and mind. Apart from limiting the spread of infections, single-patient rooms ensure privacy and confidentiality, give patients a sense of control and provide enough space for medical equipment to be wheeled in beside beds, meaning that patients can stay in their rooms for routine exams, treatments or tests.


'/>"/>

Contact: Julie Robert
julie.robert@muhc.mcgill.ca
514-843-1560
McGill University Health Centre
Source:Eurekalert

Related biology news :

1. AAAS honors Iowa State, Ames Lab researchers for distinguished science
2. New research aims to shut down viral assembly line
3. Researchers brave icy waters to study Arctic food web
4. Carnegie Mellon researchers identify Facebook neurons
5. Symposium to provide forum for best pre-clinical and translational bone research
6. Researchers create scoring system for PTEN mutation testing
7. Researchers show how Alzheimers plaques lead to loss of nitric oxide in brain
8. Research identifies drug target for prion diseases, mad cow
9. Mayo researchers describe measles viral protein movement
10. Increasing diversity of future life science researchers
11. Biofuel grasslands better for birds than ethanol staple corn, researchers find
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/13/2017)... 13, 2017 UBM,s Advanced Design and Manufacturing ... feature emerging and evolving technology through its 3D Printing ... run alongside the expo portion of the event and ... demonstrations focused on trending topics within 3D printing and ... manufacturing event will take place June 13-15, 2017 at the ...
(Date:4/11/2017)... MELBOURNE, Florida , April 11, 2017 ... "Company"), a security technology company, announces the appointment of independent ... John Bendheim to its Board of Directors, furthering the ... ... behalf of NXT-ID, we look forward to their guidance and ...
(Date:4/4/2017)... , April 4, 2017   EyeLock LLC ... announced that the United States Patent and Trademark Office ... broadly covers the linking of an iris image with ... transaction) and represents the company,s 45 th issued ... patent is very timely given the multi-modal biometric capabilities ...
Breaking Biology News(10 mins):
(Date:10/11/2017)... ... October 11, 2017 , ... Disappearing forests and increased ... of over 5.5 million people each year. Especially those living in larger cities are ... - based in one of the most pollution-affected countries globally - decided to take ...
(Date:10/11/2017)... Tampa Bay, Florida (PRWEB) , ... October 11, ... ... Food and Drug Administration (FDA) has granted orphan drug designation to SBT-100, its ... antibody (sdAb) for the treatment of osteosarcoma. SBT-100 is able to cross the ...
(Date:10/10/2017)... , ... October 10, 2017 ... ... cancer-focused pharmaceutical company advancing targeted antibody-drug conjugate (ADC) therapeutics, today confirmed licensing ... HPLN (Hybrid Polymerized Liposomal Nanoparticle), a technology developed in collaboration with Children’s ...
(Date:10/10/2017)... (PRWEB) , ... October 10, 2017 , ... Dr. Bob ... at his local San Diego Rotary Club. The event entitled “Stem ... CA and had 300+ attendees. Dr. Harman, DVM, MPVM was joined by two ...
Breaking Biology Technology: